Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Carl Icahn
MedTech
Icahn sues Illumina and its board over Grail deal fallout
Carl Icahn’s proxy battle against Illumina led to the resignation of its chairman and CEO. Now, the investor is going after the rest of the board.
Conor Hale
Oct 24, 2023 3:15pm
SEC to probe Illumina acquisition amid Grail deal fallout
Aug 11, 2023 10:41am
Illumina hit by record €432M fine for false start on Grail deal
Jul 12, 2023 9:24am
Illumina CEO Francis deSouza resigns after proxy battle
Jun 12, 2023 10:30am
Illumina to chase $100M-plus in cuts as margins narrow
Apr 26, 2023 12:01pm
Illumina sets deadline for proxy fight over board seats
Apr 21, 2023 10:35am
